Assessment of real world first line treatment patterns and outcomes in patients with recurrent metastatic Squamous Cell Carcinoma of the Head and Neck
Latest Information Update: 24 Nov 2020
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 24 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research